Hiroshi Kanno
Department of Neurosurgery
Yokohama City University School of Medicine
Yokohama
Japan
Name/email consistency: high
- Spinal cord hemangioblastomas in von Hippel-Lindau disease. Kanno, H., Yamamoto, I., Nishikawa, R., Matsutani, M., Wakabayashi, T., Yoshida, J., Shitara, N., Yamasaki, I., Shuin, T. Spinal. Cord (2009)
- Neuronal differentiation of neural progenitor cells by intracellular delivery of synthetic oligopeptide derived from Von Hippel-Lindau protein. Kanno, H., Nakano, S., Kubo, A., Mimura, T., Tajima, N., Sugimoto, N. Protein Pept. Lett. (2009)
- Intraoperative power Doppler ultrasonography with a contrast-enhancing agent for intracranial tumors. Kanno, H., Ozawa, Y., Sakata, K., Sato, H., Tanabe, Y., Shimizu, N., Yamamoto, I. J. Neurosurg. (2005)
- Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease. Kanno, H., Yamamoto, I., Yoshida, M., Kitamura, H. Neurology (2003)
- Role of the von Hippel-Lindau tumor suppressor protein during neuronal differentiation. Kanno, H., Saljooque, F., Yamamoto, I., Hattori, S., Yao, M., Shuin, T., U, H.S. Cancer Res. (2000)
- Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma. Kanno, H., Hattori, S., Sato, H., Murata, H., Huang, F.H., Hayashi, A., Suzuki, N., Yamamoto, I., Kawamoto, S., Minami, M., Miyatake, S., Shuin, T., Kaplitt, M.G. Cancer Gene Ther. (1999)









